Search clinical trials for: LEO 80185 (Taclonex® Scalp topical suspension/Xamiol® gel)

Total 8 results

LEO Pharma

Completed

Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis

Scalp Psoriasis

United States
LEO Pharma

Completed

Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis

Scalp Psoriasis

Canada, United Kingdom, France
LEO Pharma

Completed

Effect of LEO 80185 Gel on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis Vulgaris

Psoriasis Vulgaris

Canada
LEO Pharma
CMIC Co, Ltd. Japan

Completed

LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis

Psoriasis Vulgaris

Japan
LEO Pharma
Tigermed Consulting Co., Ltd

Completed

Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population

Psoriasis Vulgaris

China
LEO Pharma

Completed

Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis

Scalp Psoriasis

China
Taro Pharmaceuticals USA

Completed

To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis

Scalp Psoriasis

United States
Wake Forest University
LEO Pharma

Completed

Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris (PSTaclonex)

Plaque Psoriasis

United States

3

Subscribe